Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.750
-0.010 (-0.57%)
At close: Mar 30, 2026, 4:00 PM EDT
1.885
+0.135 (7.72%)
After-hours: Mar 30, 2026, 6:23 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $13.98 million as of March 30, 2026. Its market cap has increased by 0.66% in one year.
Market Cap
13.98M
Enterprise Value
7.56M
1-Year Change
0.66%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $13.98M, a decrease of -96.58%. That is a compound annual growth rate of -23.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 14.06M | 55.75% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 15.28M |
| Phio Pharmaceuticals | 14.64M |
| Cocrystal Pharma | 14.20M |
| IO Biotech | 13.89M |
| IN8bio | 13.88M |
| Genenta Science | 13.59M |
| Hoth Therapeutics | 13.10M |
| Moleculin Biotech | 13.02M |